Email address
[email protected]Contact number
+1 202 346 4226Share profile
Band 3
Provided by Julie Tibbets
Julie Tibbets chairs Goodwin’s Life Sciences Regulatory & Compliance practice at the firm and co-chairs Goodwin’s Rare Disease Initiative. In addition, she co-chairs Goodwin’s firmwide Attorney Review Committee.
Julie focuses her practice on FDA-regulated product development, clinical research, product marketing and enforcement as well as the intersection of each of those with corporate strategy and securities disclosure obligations. Her product areas of focus include biologics, drugs, medical devices, digital therapeutics, clinical decision support tools and mobile medical apps. She also leads the regulatory due diligence reviews of FDA-regulated M&A or investment targets, potential collaborators, and licensees, and guides the regulatory disclosures of FDA-regulated entities in their initial public offerings and follow-on offerings. Julie also works closely with the Food & Healthy Living practice team at Goodwin on the intersection of food, supplement, and cosmetic regulation with FDA’s drug and device authorities.
JD, 2004
University of North Carolina, Chapel Hill (Member, Law Review)
BA, 2001
Purdue University (Highest Honors, Phi Beta Kappa)
Provided by Chambers
Julie Tibbets heads the firm's life sciences regulatory and compliance group. She has extensive experience advising emerging and established life sciences companies on a wide range of development, marketing and enforcement matters.
Provided by Chambers
Julie is a highly experienced professional who knows the needs of biotech startups.
Julie is super-knowledgeable and accessible at all hours of the day. She is a trusted business partner and provides high-quality work product.
Julie is a highly experienced professional who knows the needs of biotech startups.
Julie is super-knowledgeable and accessible at all hours of the day. She is a trusted business partner and provides high-quality work product.
